Pages that link to "Q43699831"
Jump to navigation
Jump to search
The following pages link to Systemic sulpiride increases dopamine metabolites in the lateral hypothalamus (Q43699831):
Displaying 15 items.
- Body weight gain induced by antipsychotic drugs: mechanisms and management (Q33708467) (← links)
- Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities (Q34230366) (← links)
- Schizophrenia, the metabolic syndrome and diabetes (Q35779054) (← links)
- Atypical antipsychotic-induced weight gain: insights into mechanisms of action (Q37963571) (← links)
- Sulpiride: an antipsychotic with selective dopaminergic antagonist properties (Q40529599) (← links)
- The antipsychotic drug sulpiride does not affect bodyweight in male rats. Is insulin resistance involved? (Q44054578) (← links)
- Comparative effects of the antipsychotics sulpiride or risperidone in rats. I: bodyweight, food intake, body composition, hormones and glucose tolerance (Q44223742) (← links)
- Metoclopramide and unintended weight gain (Q44536804) (← links)
- Mechanism of the sex-dependent effect of lithium on body weight in rats (Q44720184) (← links)
- Antipsychotic drug-induced weight gain: development of an animal model (Q46408562) (← links)
- Energy homeostasis and body weight in obesity: new physiopathological and therapeutic considerations (Q47225355) (← links)
- Antipsychotic drug-induced obesity in rats: correlation between leptin, insulin and body weight during sulpiride treatment (Q47247035) (← links)
- Prolactin does not enhance glucose-stimulated insulin release in red deer stags (Q71950339) (← links)
- Mechanism of the neuroleptic-induced obesity in female rats (Q74417572) (← links)
- Glucose tolerance and serum insulin levels in an animal model of obesity induced by sub-acute or chronic administration of antipsychotic drugs (Q77882065) (← links)